What is the current valuation of the India DNA synthesis market?

The overall market valuation was $181.36 Million in 2024. Read More

What is the projected market size for the India DNA synthesis market by 2035?

The projected valuation for 2035 is $910.81 Million. Read More

What is the expected CAGR for the India DNA synthesis market during 2025 - 2035?

The expected CAGR for the market during this period is 15.8%. Read More

What are the estimated market values for the Synthetic Biology segment?

The Synthetic Biology segment is estimated to grow from $50.0 Million to $250.0 Million. Read More

Who are the leading companies in the India DNA synthesis market?

Key players include Thermo Fisher Scientific, Illumina, Integrated DNA Technologies, and GenScript. Read More

What product types are prevalent in the India DNA synthesis market?

Prominent product types include Oligonucleotides, Gene Fragments, and Gene Libraries. Read More

What is the market value range for Gene Fragments in the India DNA synthesis market?

The market value for Gene Fragments ranges from $72.68 Million to $363.4 Million. Read More

What technology segments are utilized in the India DNA synthesis market?

Technology segments include Solid-Phase Synthesis, Liquid-Phase Synthesis, and PCR-Based Synthesis. Read More

India DNA Synthesis Market

Q: Which application segments are driving growth in the India DNA synthesis market?

Key application segments include Gene Therapy, Synthetic Biology, Molecular Diagnostics, and Vaccine Development. Read More

Q: Which end users are contributing to the growth of the India DNA synthesis market?

End users include Academic Research Institutions, Pharmaceutical Companies, Biotechnology Companies, and Clinical Laboratories. Read More

ID: MRFR/MED/50503-HCR

200 Pages

Vikita Thakur

Last Updated: February 06, 2026

India DNA Synthesis Market Research Report: Size, Share, Trend Analysis By Applications (Gene Therapy, Synthetic Biology, Molecular Diagnostics, Vaccine Development), By Product Type (Oligonucleotides, Gene Fragments, Gene Libraries), By End Users (Academic Research Institutions, Pharmaceutical Companies, Biotechnology Companies, Clinical Laboratories) and By Technology (Solid-Phase Synthesis, Liquid-Phase Synthesis, PCR-Based Synthesis) - Growth Outlook & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Application (USD Million)
  1. 4.1.1 Gene Therapy
  2. 4.1.2 Synthetic Biology
  3. 4.1.3 Molecular Diagnostics
  4. 4.1.4 Vaccine Development
2. 4.2 Medical Device, BY Product Type (USD Million)
  1. 4.2.1 Oligonucleotides
  2. 4.2.2 Gene Fragments
  3. 4.2.3 Gene Libraries
3. 4.3 Medical Device, BY End User (USD Million)
  1. 4.3.1 Academic Research Institutions
  2. 4.3.2 Pharmaceutical Companies
  3. 4.3.3 Biotechnology Companies
  4. 4.3.4 Clinical Laboratories
4. 4.4 Medical Device, BY Technology (USD Million)
  1. 4.4.1 Solid-Phase Synthesis
  2. 4.4.2 Liquid-Phase Synthesis
  3. 4.4.3 PCR-Based Synthesis
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Thermo Fisher Scientific (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Illumina (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Integrated DNA Technologies (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Eurofins Genomics (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 GenScript (CN)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Twist Bioscience (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Bioneer (KR)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 DNA Script (FR)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Synthego (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 INDIA MARKET ANALYSIS BY APPLICATION
3. 6.3 INDIA MARKET ANALYSIS BY PRODUCT TYPE
4. 6.4 INDIA MARKET ANALYSIS BY END USER
5. 6.5 INDIA MARKET ANALYSIS BY TECHNOLOGY
6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
12. 6.12 MEDICAL DEVICE, BY APPLICATION, 2024 (% SHARE)
13. 6.13 MEDICAL DEVICE, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 MEDICAL DEVICE, BY PRODUCT TYPE, 2024 (% SHARE)
15. 6.15 MEDICAL DEVICE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
16. 6.16 MEDICAL DEVICE, BY END USER, 2024 (% SHARE)
17. 6.17 MEDICAL DEVICE, BY END USER, 2024 TO 2035 (USD Million)
18. 6.18 MEDICAL DEVICE, BY TECHNOLOGY, 2024 (% SHARE)
19. 6.19 MEDICAL DEVICE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY PRODUCT TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
  4. 7.2.4 BY TECHNOLOGY, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

India India DNA Synthesis Market Segmentation

India DNA Synthesis Market By Application (USD Million, 2025-2035)

Gene Therapy
Synthetic Biology
Molecular Diagnostics
Vaccine Development

India DNA Synthesis Market By Product Type (USD Million, 2025-2035)

Oligonucleotides
Gene Fragments
Gene Libraries

India DNA Synthesis Market By End User (USD Million, 2025-2035)

Academic Research Institutions
Pharmaceutical Companies
Biotechnology Companies
Clinical Laboratories

India DNA Synthesis Market By Technology (USD Million, 2025-2035)

Solid-Phase Synthesis
Liquid-Phase Synthesis
PCR-Based Synthesis

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”